Editorial

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Editorial

Contributors to the 2020 China IP Focus have written about a versatile range of issues, providing useful information for anyone with commercial interests in the jurisdiction. Indeed there are many articles in this supplement which will help foreign entities navigate China's IP terrain, including pieces on how right holders can enforce their IP in China, how US and Chinese disclosure practices compare and how to select Chinese language marks (if the applicant owns a trademark in a foreign language and wants to register a Chinese equivalent).

The Red Canned Herbal Tea judgment is highlighted as an important judgment for the intersection between IP and unfair competition law and the risks involved in trademark licensing. The Honda decision is also covered in some depth in this focus. This reversed a previous SPC ruling in the Pretul case. The Honda case deemed affixation of a trademark on a product solely intended for export by an OEM, "use" of a trademark. Both the Red Canned Herbal Tea and Honda judgments were selected as key cases by the SPC.

The articles in this issue of the China IP Focus also deal with other relevant matters, such as the evidence rules in IP litigation and the different defences in a patent infringement claim. We hope, here at Managing IP, that this supplement will be a useful stepping stone to understanding China's IP laws.

Sanjana Kapila

Commercial projects editor

Managing IP

more from across site and SHARED ros bottom lb

More from across our site

AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has seemingly committed to hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
In-house counsel aren’t impressed with law firms’ international networks, but practitioners say they are crucial for business
Gift this article